Angiodynamics Stock Performance
| ANGO Stock | USD 10.24 0.09 0.87% |
The firm shows a Beta (market volatility) of 1.05, which signifies a somewhat significant risk relative to the market. AngioDynamics returns are very sensitive to returns on the market. As the market goes up or down, AngioDynamics is expected to follow. At this point, AngioDynamics has a negative expected return of -0.22%. Please make sure to confirm AngioDynamics' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if AngioDynamics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AngioDynamics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (0.87) | Five Day Return (3.40) | Year To Date Return (19.24) | Ten Year Return (2.94) | All Time Return (18.08) |
1 | Disposition of 3673 shares by James Clemmer of AngioDynamics at 8.99 subject to Rule 16b-3 | 12/10/2025 |
2 | Acquisition by Lawrence Weiss of 30900 shares of AngioDynamics subject to Rule 16b-3 | 12/24/2025 |
3 | AngioDynamics Q1 2026 Earnings Transcript | 01/06/2026 |
4 | AngioDynamics, Inc. Q2 2026 Earnings Call Transcript | 01/07/2026 |
5 | Acquisition by Licitra Karen A of 20541 shares of AngioDynamics subject to Rule 16b-3 | 01/08/2026 |
6 | Assessing AngioDynamics Valuation After Raised Guidance And Med Tech Momentum | 01/09/2026 |
7 | Down 25.0 percent in 4 Weeks, Heres Why You Should You Buy the Dip in AngioDynamics | 01/12/2026 |
8 | Global Tumor Ablation Market Set to Reach USD 1.4 Billion by 2029 MarketsandMarkets | 01/15/2026 |
| Begin Period Cash Flow | 76.1 M | |
| Total Cashflows From Investing Activities | -10.2 M |
AngioDynamics | Build AI portfolio with AngioDynamics Stock |
AngioDynamics Relative Risk vs. Return Landscape
If you would invest 1,212 in AngioDynamics on October 29, 2025 and sell it today you would lose (184.50) from holding AngioDynamics or give up 15.22% of portfolio value over 90 days. AngioDynamics is currently does not generate positive expected returns and assumes 3.0627% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than AngioDynamics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AngioDynamics Target Price Odds to finish over Current Price
The tendency of AngioDynamics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.24 | 90 days | 10.24 | over 95.93 |
Based on a normal probability distribution, the odds of AngioDynamics to move above the current price in 90 days from now is over 95.93 (This AngioDynamics probability density function shows the probability of AngioDynamics Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.05 . This suggests AngioDynamics market returns are highly reactive to returns on the market. As the market goes up or down, AngioDynamics is expected to follow. Additionally AngioDynamics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. AngioDynamics Price Density |
| Price |
Predictive Modules for AngioDynamics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AngioDynamics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AngioDynamics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AngioDynamics is not an exception. The market had few large corrections towards the AngioDynamics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AngioDynamics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AngioDynamics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.3 | |
β | Beta against Dow Jones | 1.05 | |
σ | Overall volatility | 1.09 | |
Ir | Information ratio | -0.1 |
AngioDynamics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AngioDynamics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AngioDynamics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AngioDynamics generated a negative expected return over the last 90 days | |
| AngioDynamics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 292.5 M. Net Loss for the year was (33.99 M) with profit before overhead, payroll, taxes, and interest of 167.72 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: The Analyst Verdict Treace Medical Concepts In The Eyes Of 6 Experts |
AngioDynamics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AngioDynamics Stock often depends not only on the future outlook of the current and potential AngioDynamics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AngioDynamics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41 M | |
| Cash And Short Term Investments | 55.9 M |
AngioDynamics Fundamentals Growth
AngioDynamics Stock prices reflect investors' perceptions of the future prospects and financial health of AngioDynamics, and AngioDynamics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AngioDynamics Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.046 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 386.02 M | ||||
| Shares Outstanding | 41.22 M | ||||
| Price To Earning | 7.90 X | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 1.37 X | ||||
| Revenue | 292.5 M | ||||
| Gross Profit | 167.72 M | ||||
| EBITDA | 1.74 M | ||||
| Net Income | (33.99 M) | ||||
| Cash And Equivalents | 24.56 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 3.95 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 2.28 X | ||||
| Book Value Per Share | 4.24 X | ||||
| Cash Flow From Operations | (10.13 M) | ||||
| Earnings Per Share | (0.67) X | ||||
| Market Capitalization | 422.07 M | ||||
| Total Asset | 280.14 M | ||||
| Retained Earnings | (429.2 M) | ||||
| Working Capital | 92.13 M | ||||
| Current Asset | 146.25 M | ||||
| Current Liabilities | 66.73 M | ||||
About AngioDynamics Performance
By examining AngioDynamics' fundamental ratios, stakeholders can obtain critical insights into AngioDynamics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that AngioDynamics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 193.09 | 163.78 | |
| Return On Tangible Assets | (0.19) | (0.18) | |
| Return On Capital Employed | (0.23) | (0.21) | |
| Return On Assets | (0.14) | (0.13) | |
| Return On Equity | (0.17) | (0.18) |
Things to note about AngioDynamics performance evaluation
Checking the ongoing alerts about AngioDynamics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AngioDynamics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AngioDynamics generated a negative expected return over the last 90 days | |
| AngioDynamics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 292.5 M. Net Loss for the year was (33.99 M) with profit before overhead, payroll, taxes, and interest of 167.72 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: The Analyst Verdict Treace Medical Concepts In The Eyes Of 6 Experts |
- Analyzing AngioDynamics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AngioDynamics' stock is overvalued or undervalued compared to its peers.
- Examining AngioDynamics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AngioDynamics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AngioDynamics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AngioDynamics' stock. These opinions can provide insight into AngioDynamics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.09 | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.